Literature DB >> 16830363

Antioxidant role of heme oxygenase-1 in prehepatic portal hypertensive rats.

Soledad Gonzales1, Maria-Julia Perez, Juan-C Perazzo, Maria-Lujan Tomaro.   

Abstract

AIM: To study the effect of bilirubin on the oxidative liver status and the activity and expression of heme oxygenase-1 (HO-1) in rat liver injury induced by prehepatic portal hypertension.
METHODS: Wistar male rats, weighing 200-250 g, were divided at random into two groups: one group with prehepatic portal hypertension (PH) induced by regulated prehepatic portal vein ligation (PPVL) and the other group corresponded to sham operated rats. Portal pressure, oxidative stress parameters, antioxidant enzymes, HO-1 activity and expression and hepatic sinusoidal vasodilatation were measured.
RESULTS: In PPVL rats oxidative stress was evidenced by a marked increase in thiobarbituric acid reactive substances (TBARS) content and a decrease in reduced glutathione (GSH) levels. The activities of liver antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) were also diminished while activity and expression of HO-1 were enhanced. Administration of bilirubin (5 mumol/kg body weight) 24 h before the end of the experiment entirely prevented all these effects. Pretreatment with Sn-protoporphyrin IX (Sn-PPIX) (100 mug/kg body weight, i.p.), a potent inhibitor of HO, completely abolished the oxidative stress and provoked a slight decrease in liver GSH levels as well as an increase in lipid peroxidation. Besides, carbon monoxide, another heme catabolic product, induced a significant increase in sinusoidal hepatic areas in PPVL group. Pretreatment of PPVL rats with Sn-PPIX totally prevented this effect.
CONCLUSION: These results suggest a beneficial role of HO-1 overexpression in prehepatic portal hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830363      PMCID: PMC4087362          DOI: 10.3748/wjg.v12.i26.4149

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Heme oxygenase-1: a cellular Hercules.

Authors:  Brian S Zuckerbraun; Timothy R Billiar
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 2.  Bilirubin: its role in cytoprotection against oxidative stress.

Authors:  María L Tomaro; Alcira M del C Batlle
Journal:  Int J Biochem Cell Biol       Date:  2002-03       Impact factor: 5.085

3.  Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis.

Authors:  M Masseroli; T Caballero; F O'Valle; R M Del Moral; A Pérez-Milena; R G Del Moral
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

Review 4.  Heme oxygenase: colors of defense against cellular stress.

Authors:  L E Otterbein; A M Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

5.  Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases.

Authors:  N Makino; M Suematsu; Y Sugiura; H Morikawa; S Shiomi; N Goda; T Sano; Y Nimura; K Sugimachi; Y Ishimura
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

6.  Bilirubin is highly effective in preventing in vivo delta-aminolevulinic acid-induced oxidative cell damage.

Authors:  Guillermo O Noriega; María L Tomaro; Alcira M C del Batlle
Journal:  Biochim Biophys Acta       Date:  2003-07-14

7.  Decreased oxidative stress in prehepatic portal hypertensive rat livers following the induction of diabetes.

Authors:  P Evelson; S Llesuy; E Filinger; R R Rodriguez; A Lemberg; C Scorticati; M Susemihl; I Villareal; J M Polo; H Peredo; J C Perazzo
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-03       Impact factor: 2.557

8.  Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane.

Authors:  Mercedes Fernandez; Herbert L Bonkovsky
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

9.  Altered blood-brain barrier permeability in rats with prehepatic portal hypertension turns to normal when portal pressure is lowered.

Authors:  Francisco Eizayaga; Camila Scorticati; Juan-P Prestifilippo; Salvador Romay; Maria-A Fernandez; Jose-L Castro; Abraham Lemberg; Juan-C Perazzo
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 10.  Heme oxygenase-1: unleashing the protective properties of heme.

Authors:  Leo E Otterbein; Miguel P Soares; Kenichiro Yamashita; Fritz H Bach
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

View more
  4 in total

1.  Antioxidant properties of blirubin in the model organism, Caenorhabditis elegans.

Authors:  Danny McCaughan; Catherine Au; Alexandre Benedetto; Dejan Milatovic; Judy Aschner; Michael Aschner
Journal:  Int J Neuroprot Neuroregener       Date:  2008

2.  Transport Stress Induced Cardiac NO-NOS Disorder Is Mitigated by Activating Nrf2/HO-1/NQO1 Antioxidant Defense Response in Newly Hatched Chicks.

Authors:  Hao-Liang Xu; Hui Li; Rong-Kun Bao; Yi-Xi Tang; Ahmed Ibrahim Ahmed Elsherbeni; Hassan Bayoumi Ali Gharib; Jin-Long Li
Journal:  Front Vet Sci       Date:  2022-06-10

3.  Glutamine prevents oxidative stress in a model of portal hypertension.

Authors:  Gilmara Pandolfo Zabot; Gustavo Franco Carvalhal; Norma Possa Marroni; Francielli Licks; Renata Minuzzo Hartmann; Vinícius Duval da Silva; Henrique Sarubbi Fillmann
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

4.  Effects of Titanium Dioxide Nanoparticles on Porcine Prepubertal Sertoli Cells: An "In Vitro" Study.

Authors:  Francesca Mancuso; Iva Arato; Alessandro Di Michele; Cinzia Antognelli; Luca Angelini; Catia Bellucci; Cinzia Lilli; Simona Boncompagni; Aurora Fusella; Desirée Bartolini; Carla Russo; Massimo Moretti; Morena Nocchetti; Angela Gambelunghe; Giacomo Muzi; Tiziano Baroni; Stefano Giovagnoli; Giovanni Luca
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.